Verastem Inc (VSTM)
10.90
+0.54
(+5.21%)
USD |
NASDAQ |
May 03, 16:00
10.57
-0.33
(-3.03%)
After-Hours: 20:00
Verastem Accounts Payable (Quarterly): 7.184M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 7.184M |
September 30, 2023 | 5.118M |
June 30, 2023 | 4.553M |
March 31, 2023 | 4.903M |
December 31, 2022 | 4.901M |
September 30, 2022 | 5.359M |
June 30, 2022 | 1.706M |
March 31, 2022 | 2.896M |
December 31, 2021 | 2.302M |
September 30, 2021 | 0.641M |
June 30, 2021 | 1.395M |
March 31, 2021 | 2.453M |
December 31, 2020 | 1.875M |
September 30, 2020 | 4.681M |
June 30, 2020 | 2.241M |
March 31, 2020 | 7.233M |
December 31, 2019 | 9.655M |
September 30, 2019 | 8.842M |
June 30, 2019 | 11.54M |
March 31, 2019 | 8.593M |
December 31, 2018 | 10.25M |
September 30, 2018 | 11.25M |
June 30, 2018 | 8.514M |
March 31, 2018 | 7.267M |
December 31, 2017 | 9.186M |
Date | Value |
---|---|
September 30, 2017 | 7.363M |
June 30, 2017 | 6.825M |
March 31, 2017 | 8.809M |
December 31, 2016 | 4.095M |
September 30, 2016 | 1.962M |
June 30, 2016 | 2.149M |
March 31, 2016 | 2.595M |
December 31, 2015 | 3.942M |
September 30, 2015 | 3.646M |
June 30, 2015 | 2.999M |
March 31, 2015 | 3.951M |
December 31, 2014 | 3.216M |
September 30, 2014 | 3.299M |
June 30, 2014 | 3.159M |
March 31, 2014 | 2.515M |
December 31, 2013 | 2.76M |
September 30, 2013 | 1.836M |
June 30, 2013 | 2.034M |
March 31, 2013 | 1.926M |
December 31, 2012 | 1.848M |
September 30, 2012 | 1.737M |
June 30, 2012 | 2.45M |
March 31, 2012 | 1.936M |
December 31, 2011 | 2.273M |
September 30, 2011 | 1.246M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.641M
Minimum
Sep 2021
11.54M
Maximum
Jun 2019
4.709M
Average
4.681M
Median
Sep 2020
Accounts Payable (Quarterly) Benchmarks
Johnson & Johnson | 8.174B |
Geron Corp | 9.992M |
Altimmune Inc | 2.07M |
Oragenics Inc | 1.245M |
Actinium Pharmaceuticals Inc | -- |